Community-Based Physical Activity Intervention for Underserved Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRoswell Park Cancer Institute

About this trial

This clinical trial evaluates a community-based physical activity program for underserved cancer survivors. Cancer and its treatment significantly influence physical, psychosocial, and cognitive functioning. Historically, community sites (local and national) have not been staffed to offer support services such as physical, and occupational therapies (everyday life activities to promote health and well-being) or nutrition counselling, and do not offer a whole-person model of care. In this study, researchers have partnered with the YMCA to provide tailored home-based exercise programs for underserved cancer patients and survivors. Accessing exercise professionals may allow patients to prevent acute problems from becoming chronic, long-lasting physically weak impairments that directly influence patients' quality of life.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Have had a previous cancer diagnosis OR are a caregiver for a patient who has had a previous cancer diagnosis

Not in active treatment for cancer

Over 18 years of age

Disqualifiers

Have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, atrial fibrillation (AFIB), multiple myeloma, or psychiatric illness/social situations that would limit compliance with study requirements

Have orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise

Are pregnant or nursing - self reported by participant

Are unwilling or unable to follow protocol requirements

Trial design

Design model

Single group

Treatments tested in this trial

  • Exercise Intervention

    Other intervention

    Participate in virtual exercise classes

  • Questionnaire Administration

    Other intervention

    Ancillary studies

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Supportive Care (virtual exercise classes)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Proportion of patients referred to the intervention (Feasibility)

At the provider level, feasibility will be defined as the proportion of patients that were referred to the intervention versus (vs.) the proportion of patients that enrolled in the study. Will estimate the referral rates with 95% confidence intervals obtained from generalized estimating equation (GEE) logistic regression models, accounting for the within provider clustering.

Time frame
Up to 12 weeks
2

Proportion of patients that enrolled in the study (Feasibility)

At the provider level, feasibility will be defined as the proportion of patients that were referred to the intervention vs. the proportion of patients that enrolled in the study.

Time frame
Up to 12 weeks
3

Retention rate (Feasibility)

At the patient level, feasibility will be defined as the proportion of patients still on study. Will estimate with 95% confidence intervals obtained from GEE logistic regression models, accounting for the within provider clustering.

Time frame
At the end of the 12-week intervention
4

Adherence rate (Acceptability)

Adherence will be defined as the percentage of patients on study after 12-weeks who complete at least 70% of the intervention videos. Will estimate with 95% confidence intervals obtained from GEE logistic regression models, accounting for the within provider clustering.

Time frame
At post 12-weeks

Secondary outcomes

1

Overall quality of life

Will assess the changes in physical functioning, sustained physical activity, and quality of life using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) score.

Time frame
Up to 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.